Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.

Tai CJ, Chin-Sheng H, Kuo LJ, Wei PL, Lu HH, Chen HA, Liu TZ, Liu JJ, Liu DZ, Ho YS, Wu CH, Chang YJ.

Ann Surg Oncol. 2012 Jan;19(1):336-43. doi: 10.1245/s10434-011-1692-5. Epub 2011 Apr 23.

PMID:
21516372
2.

Silencing of glucose-regulated protein 78 (GRP78) enhances cell migration through the upregulation of vimentin in hepatocellular carcinoma cells.

Wei PL, Kuo LJ, Wang W, Lin FY, Liu HH, How T, Ho YS, Huang MT, Wu CH, Chang YJ.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S572-9. doi: 10.1245/s10434-011-2055-y. Epub 2011 Sep 27.

PMID:
21947694
3.

Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma.

Chang YJ, Tai CJ, Kuo LJ, Wei PL, Liang HH, Liu TZ, Wang W, Tai CJ, Ho YS, Wu CH, Huang MT.

Ann Surg Oncol. 2011 Aug;18(8):2395-403. doi: 10.1245/s10434-011-1597-3. Epub 2011 Feb 23.

PMID:
21347788
4.

Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma.

Hung CS, Lin SF, Liu HH, Kuo LJ, Li LT, Su HY, Liew PL, Lin FY, Wei PL, Liu DZ, Chang YJ.

Ann Surg Oncol. 2012 Aug;19(8):2744-52. doi: 10.1245/s10434-011-2188-z. Epub 2012 Jan 19. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4;S780-1.

PMID:
22258814
5.

[The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].

Zhang Y, Hu MY, Chen BH, Wang ZJ, Zha XL, Liu KD.

Zhonghua Yi Xue Za Zhi. 2006 Feb 28;86(8):530-5. Chinese.

PMID:
16681881
6.

BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Han P, Fu Y, Luo M, He J, Liu J, Liao J, Tian D, Yan W.

Dig Dis Sci. 2014 May;59(5):992-1000. doi: 10.1007/s10620-013-2992-3. Epub 2014 Jan 18.

PMID:
24442236
7.

MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.

Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC, Wu CH, Ho YS, Wei PL, Chang YJ.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S360-8. doi: 10.1245/s10434-012-2482-4. Epub 2012 Aug 7.

PMID:
22868917
8.

Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.

Zhou M, Zhang XY, Yu X.

Biomed Pharmacother. 2017 Jan;85:348-354. doi: 10.1016/j.biopha.2016.11.035. Epub 2016 Nov 28.

PMID:
27899259
9.

Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference.

Wang Q, Shu R, He H, Wang L, Ma Y, Zhu H, Wang Z, Wang S, Shen G, Lei P.

Int J Oncol. 2012 Aug;41(2):652-60. doi: 10.3892/ijo.2012.1471. Epub 2012 May 10.

PMID:
22581315
10.

The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines.

Xu Y, Liu Z, Guo K.

Pathol Oncol Res. 2012 Jul;18(3):571-7. doi: 10.1007/s12253-011-9476-6. Epub 2011 Nov 23.

PMID:
22109562
11.

Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.

Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A.

Cancer Gene Ther. 2010 Apr;17(4):275-88. doi: 10.1038/cgt.2009.68. Epub 2009 Oct 30.

PMID:
19876077
12.
13.

FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.

Yu J, Zhang W, Gao F, Liu YX, Chen ZY, Cheng LY, Xie SF, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):184-91.

14.

MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.

Zhu M, Li M, Wang T, Linghu E, Wu B.

Tumour Biol. 2016 Oct;37(10):13995-14008. Epub 2016 Aug 4.

PMID:
27492460
15.

KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.

Cho SB, Park YL, Park SJ, Park SY, Lee WS, Park CH, Choi SK, Heo YH, Koh YS, Cho CK, Chung IJ, Kim KK, Kim S, Joo YE.

Oncol Res. 2011;19(3-4):115-23.

PMID:
21473287
16.

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM.

Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4.

PMID:
20525879
17.

Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells.

Li H, Song H, Luo J, Liang J, Zhao S, Su R.

J Exp Clin Cancer Res. 2012 Apr 30;31:39. doi: 10.1186/1756-9966-31-39.

18.

Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.

Liu L, Zhu XD, Wang WQ, Shen Y, Qin Y, Ren ZG, Sun HC, Tang ZY.

Clin Cancer Res. 2010 May 15;16(10):2740-50. doi: 10.1158/1078-0432.CCR-09-2610. Epub 2010 May 11.

19.

OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.

Dai X, Ge J, Wang X, Qian X, Zhang C, Li X.

Oncol Rep. 2013 Jan;29(1):155-60. doi: 10.3892/or.2012.2086. Epub 2012 Oct 17.

PMID:
23076549
20.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

PMID:
23740840

Supplemental Content

Support Center